Similar articles for PMID: 22744325

Year	Number of Results
2000	2
2004	2
2005	1
2006	1
2007	3
2008	4
2009	6
2010	2
2011	6
2012	6
2013	5
2014	3
2015	14
2016	15
2017	9
2018	10
2019	11
2020	10
2021	2
2022	4
2024	0

1

The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy.

Sherriff JM, Ogunremi B, Colley S, Sanghera P, Hartley A. Sherriff JM, et al. Br J Radiol. 2012 Nov;85(1019):e1120-6. doi: 10.1259/bjr/20976707. Epub 2012 Jun 27. Br J Radiol. 2012. PMID: 22744325 Free PMC article.

2

Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.

Loo SW, Geropantas K, Beadsmoore C, Montgomery PQ, Martin WM, Roques TW. Loo SW, et al. Clin Oncol (R Coll Radiol). 2011 Oct;23(8):512-7. doi: 10.1016/j.clon.2011.03.008. Epub 2011 Apr 17. Clin Oncol (R Coll Radiol). 2011. PMID: 21501953

3

Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.

Chaput A, Calais J, Robin P, Thureau S, Bourhis D, Modzelewski R, Schick U, Vera P, Salaün PY, Abgral R. Chaput A, et al. Head Neck. 2017 Jun;39(6):1155-1165. doi: 10.1002/hed.24738. Epub 2017 Mar 6. Head Neck. 2017. PMID: 28263422

4

The Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Cancer after Radical Chemoradiotherapy: a Single Institution Experience.

Nelissen C, Sherriff J, Jones T, Guest P, Colley S, Sanghera P, Hartley A. Nelissen C, et al. Clin Oncol (R Coll Radiol). 2017 Nov;29(11):753-759. doi: 10.1016/j.clon.2017.07.010. Epub 2017 Aug 2. Clin Oncol (R Coll Radiol). 2017. PMID: 28780008

5

FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.

Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, Fukuda H. Kubota K, et al. Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):590-5. doi: 10.1007/s00259-003-1408-6. Epub 2004 Jan 14. Eur J Nucl Med Mol Imaging. 2004. PMID: 14722678 Clinical Trial.

6

Use of Diffusion-Weighted Imaging and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.

Noij DP, Martens RM, Koopman T, Hoekstra OS, Comans EFI, Zwezerijnen B, de Bree R, de Graaf P, Castelijns JA. Noij DP, et al. Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11. Clin Oncol (R Coll Radiol). 2018. PMID: 30318343

7

Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.

Malone JP, Gerberi MA, Vasireddy S, Hughes LF, Rao K, Shevlin B, Kuhn M, Collette D, Tennenhouse J, Robbins KT. Malone JP, et al. Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1119-25. doi: 10.1001/archoto.2009.152. Arch Otolaryngol Head Neck Surg. 2009. PMID: 19917925

8

Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?

Akagunduz OO, Savas R, Yalman D, Kocacelebi K, Esassolak M. Akagunduz OO, et al. Nucl Med Biol. 2015 Nov;42(11):899-904. doi: 10.1016/j.nucmedbio.2015.06.007. Epub 2015 Jun 22. Nucl Med Biol. 2015. PMID: 26275933

9

Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.

Sagardoy T, Fernandez P, Ghafouri A, Digue L, Haaser T, de Clermont-Galleran H, Castetbon V, de Monès E. Sagardoy T, et al. Head Neck. 2016 Apr;38 Suppl 1:E1271-6. doi: 10.1002/hed.24204. Epub 2015 Aug 28. Head Neck. 2016. PMID: 26315809

10

PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.

Mehanna H, McConkey CC, Rahman JK, Wong WL, Smith AF, Nutting C, Hartley AG, Hall P, Hulme C, Patel DK, Zeidler SV, Robinson M, Sanghera B, Fresco L, Dunn JA. Mehanna H, et al. Health Technol Assess. 2017 Apr;21(17):1-122. doi: 10.3310/hta21170. Health Technol Assess. 2017. PMID: 28409743 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year